Printer Friendly
The Free Library
14,716,402 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Beating two infections with one vaccine. (Immunology).


Identifying key similarities between related bugs could enable researchers to coax some vaccines to do double duty.

Immunity to one virus sometimes confers protection against a related microbe microbe /mi·crobe/ (mi´krob) a microorganism, especially a pathogenic one such as a bacterium, protozoan, or fungus.micro´bialmicro´bic

mi·crobe
n.
. Such cross-protection is the case with cowpox cowpox, infectious disease of cows caused by a virus related to the virus of smallpox. Also called variola, it is characterized by pustular lesions on the teats and udder.  and smallpox, and a vaccine currently in use for Japanese encephalitis Japanese Encephalitis Definition

Japanese encephalitis is an infection of the brain caused by a virus. The virus is transmitted to humans by mosquitoes.
 protects some animals against the closely related West Nile virus West Nile virus, microorganism and the infection resulting from it, which typically produces no symptoms or a flulike condition. The virus is a flavivirus and is related to a number of viruses that cause encephalitis. .

Cross-protection could occur in part because related viruses share many molecular parts that trigger immune cells to attack, says Anne S. De Groot of Brown University and the company EpiVax, both in Providence, R.I.

De Groot and her colleagues compared the genomes of a Japanese encephalitis virus and a strain of West Nile virus that killed several people in New York in 1999. The researchers found that the viruses share at least 300 parts, or epitopes. This suggests that an immune cell primed to attack an epitope epitope: see immunity.  in one virus would respond to the other virus, as well.

Identifying other pairs of pathogens with many cross-reactive epitopes may reveal more double-duty vaccines, the researchers say. --B.H.
COPYRIGHT 2002 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:May 18, 2002
Words:174
Previous Article:In depression, the placebo also rises. (Behavior).(Brief Article)
Next Article:Liquid could aid vaccine storage, use. (Vaccine Design).(Brief Article)
Topics:



Related Articles
Avoiding the nightmare of drug-resistant pneumococcal pneumonia.
Superinfection (Reinfection): New Study in San Francisco Offers Free Resistance and Viral Load Testing.(Brief Article)
Science Project Director.
Immunology of infectious diseases.(Book Review)
Smallpox vaccination begins in U.S.--precautions needed.
ARC AWARDS $300,000 TO PANVAX TO DEVELOP FMDV VACCINE.
The vaccine book.(Book Review)
HIV treatment and immunology research: current ideas.
NORWOOD IMMUNOLOGY TAKES OPTION FOR VACCINE TECHNOLOGY.
Vaccine improves survival in monkey tests.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles